Scarica l'app Stockscreener
110.99
1.47%
-1.6615
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Abbott Laboratories Borsa (ABT) Ultime notizie
Molecular Diagnostics Market Outlook: Set to Grow at 10%+ CAGR Through 2031 as Precision Medicine and Genetic Testing Advance, Says Mordor Intelligence - GlobeNewswire Inc.
Abbott Laboratories (ABT) Announces $20 Billion Senior Notes Off - GuruFocus
Abbott Formula Linked To 'Horrible' Gut Disease, Ill. Jury Told - Law360
Abbott Laboratories Completes Major Senior Notes Offering - TipRanks
Abbott Laboratories Offers Long-Term Upside Despite Recent Stumbles (NYSE:ABT) - Seeking Alpha
Abbott Laboratories Pakistan : Board Meeting - marketscreener.com
A Look At Abbott Laboratories (ABT) Valuation After Recent Share Price Volatility - simplywall.st
Abbott IP chief: ‘Firms without AI policies scare me’ - Life Sciences Intellectual Property Review
Abbott Laboratories $ABT Shares Sold by Victory Capital Management Inc. - MarketBeat
Abbott Laboratories $ABT Shares Sold by Orion Porfolio Solutions LLC - MarketBeat
Abbott Faces Trial Over Claims Its Infant Formula Caused Bowel Disease in Premature Babies - The Indian Practitioner
Trial over Abbott Laboratories’ formula for premature babies set to begin this week - Times West Virginian
Crossmark Global Holdings Inc. Purchases 12,373 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott Labs to face trial on infant formula - The Economic Times
Trial over Abbott Laboratories’ formula for premature babies set to begin in Chicago this week - The Daily Gazette
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Daywatch: Trial over Abbott Laboratories’ formula for premature babies set to begin - Chicago Tribune
Abbott set to face trial over claims premature infant formula caused deadly disease - Reuters
Trial over Abbott Laboratories’ formula for premature babies set to begin in Cook County this week - Chicago Tribune
Dimensional Fund Advisors LP Purchases 169,115 Shares of Abbott Laboratories $ABT - MarketBeat
US002824BU37 Bond Price and Chart — SWB:US002824BU37 - TradingView
Abbott Laboratories EVP Cushman sells $30k in stock - Investing.com Australia
A4EQ5K Bond Price and Chart — GETTEX:A4EQ5K - TradingView
Abbott Laboratories EVP Cushman sells $30k in stock By Investing.com - Investing.com UK
Insider Selling: Abbott Laboratories (NYSE:ABT) EVP Sells 613 Shares of Stock - MarketBeat
Abbott Laboratories (NYSE:ABT) EVP Sells $102,288.30 in Stock - MarketBeat
Insider Selling: Abbott Laboratories (NYSE:ABT) EVP Sells 263 Shares of Stock - MarketBeat
Insider Sell: Elizabeth Cushman Sells Shares of Abbott Laborator - GuruFocus
Abbott (ABT) SVP Eric Shroff logs share sale and tax disposition - Stock Titan
Abbott Laboratories (ABT) EVP logs 4,997-share tax-withholding disposition on Form 4 - Stock Titan
Abbott (NYSE: ABT) EVP logs share sale and tax disposition - Stock Titan
Abbott (ABT) CEO Robert Ford disposes 30,308 shares for tax withholding - Stock Titan
Abbott Laboratories (ABT) EVP logs tax-withholding disposition of 8,577 shares - Stock Titan
Abbott Laboratories (NYSE: ABT) VP reports sale and tax share disposal - Stock Titan
Abbott Laboratories (ABT) CFO uses 7,441 shares to cover tax withholding - Stock Titan
Abbott (ABT) EVP logs stock sale and tax-withholding share disposal - Stock Titan
How FDA Approval of CardioMEMS Hero Remote Monitor At Abbott (ABT) Has Changed Its Investment Story - Yahoo Finance
Abbott Labs Finishes Off Suit Over Google, Meta Data Sharing - Bloomberg Law News
Abbott Laboratories Spent $20 Billion to Enter Cancer Diagnostics: Why Analysts See 60% Upside - TIKR.com
Exact Sciences Holders Back Abbott Deal As Valuation Gap Draws Focus - simplywall.st
Better Value & Growth: STE, RMD Lead Abbott Laboratories Stock - Trefis
Abbott Laboratories Stock: Is This Quiet Health Tech Giant Your Next Big US Play? - AD HOC NEWS
Is Abbott Laboratories (ABT) Pricing Look Attractive After Recent Share Price Weakness? - simplywall.st
Abbott Beats Data Sharing Suit Over Glucose Tracking Trial - Law360
[144] ABBOTT LABORATORIES SEC Filing - Stock Titan
Abbott (ABT) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
Abbott Laboratories stock underperforms Monday when compared to competitors - MarketWatch
Futures Contracts for Abbott Laboratories Futures - TradingView
NICE recommends leadless pacemakers to treat slow heart rhythms - BioWorld MedTech
2 Reasons to Like ABT and 1 to Stay Skeptical - StockStory
Abbott wins FDA approval for updated heart failure monitoring device - MedTech Dive
Abbott Laboratories (NYSE:ABT) Emerges as a Top Dividend Stock with Strong Fundamentals - ChartMill
Fisher Asset Management LLC Raises Stock Position in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Sold by Laurel Wealth Advisors LLC - MarketBeat
Abbott Laboratories stock forecast for 2030: Exact Sciences acquisition reshapes growth outlook toward $180 - Traders Union
Antibiotics Market - GlobeNewswire Inc.
Rafferty Asset Management LLC Purchases 9,290 Shares of Abbott Laboratories $ABT - MarketBeat
APG Asset Management N.V. Acquires 12,600 Shares of Abbott Laboratories $ABT - MarketBeat
Exact Sciences Vote Clears Path To Abbott Deal And Valuation Recheck - simplywall.st
Harvest Portfolios Group Inc. Raises Stake in Abbott Laboratories $ABT - MarketBeat
Allianz SE Reduces Position in Abbott Laboratories $ABT - MarketBeat
Exact Sciences (EXAS) Merger with Abbott Moving Forward After Shareholder Approval - Finviz
Abbott Laboratories : next‑generation CardioMEMS™ remote heart failure monitoring reader receives FDA approval to enhance patient experience and help detect disease progression - marketscreener.com
Xponance Inc. Sells 31,276 Shares of Abbott Laboratories $ABT - MarketBeat
Primecap Management Co. CA Sells 65,100 Shares of Abbott Laboratories $ABT - MarketBeat
1.24%
1.60%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):